Cerus Corporation to Participate in Upcoming Investor Conferences
Business Wire•17/11/2026•16:01 ET
0
Key Highlights
- ➤Cerus management to hold one-on-one meetings at Citi’s 2026 Global Healthcare Conference
- ➤Cerus management to hold one-on-one meetings at Piper Sandler’s 38th Annual Healthcare Conference
- ➤INTERCEPT red blood cell system under regulatory review in Europe and late-stage U.S. development
- ➤INTERCEPT Fibrinogen Complex approved in the U.S. for bleeding associated with fibrinogen deficiency
Cerus Corporation to Participate in Upcoming Investor Conferences
Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management will participate in the following upcoming investor conferences.
Get started
Create a free account to read the full story.
